Thrive Capital Management (Pennsylvania)’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-956	Closed	-$214K	–	190
2025 Q1	$214K	Buy	+956	New	+$263K	0.13%	110
2024 Q4	–	Sell	-965	Closed	-$290K	–	178
2024 Q3	$290K	Hold	965	–	–	0.14%	155
2024 Q2	$318K	Hold	965	–	–	0.15%	154
2024 Q1	$382K	Hold	965	–	–	0.2%	66
2023 Q4	$340K	Sell	965 -6	-0.6%	-$2.12K	0.18%	89
2023 Q3	$364K	Hold	971	–	–	0.2%	81
2023 Q2	$371K	Buy	971 +9	+0.9%	+$3.21K	0.21%	82
2023 Q1	$328K	Hold	962	–	–	0.21%	82
2022 Q4	$226K	Hold	962	–	–	0.15%	105
2022 Q3	$237K	Hold	962	–	–	0.16%	98
2022 Q2	$291K	Sell	962 -10	-1%	-$3.25K	0.2%	80
2022 Q1	$399K	Buy	972 +10	+1%	+$3.92K	0.24%	60
2021 Q4	$451K	Buy	+962	New	+$414K	0.29%	69
2021 Q3	–	Sell	-962	Closed	-$345K	–	110
2021 Q2	$345K	Hold	962	–	–	0.27%	89
2021 Q1	$271K	Hold	962	–	–	0.25%	99
2020 Q4	$273K	Buy	+962	New	+$270K	0.29%	69